These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33911702)

  • 1. Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31.
    Park SM; Kim GW; Kim HS; Ko HC; Kim MB; Kim BS
    Ann Dermatol; 2020 Feb; 32(1):1-7. PubMed ID: 33911702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuropeptides and perception of pruritus in psoriasis.
    Reich A; Orda A; Wiśnicka B; Szepietowski JC
    Acta Derm Venereol; 2007; 87(4):299-304. PubMed ID: 17598031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.
    Choe YB; Hwang YJ; Hahn HJ; Jung JW; Jung HJ; Lee YW; Ahn KJ; Youn JI
    Br J Dermatol; 2012 Oct; 167(4):762-7. PubMed ID: 22564054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides and their receptors in psoriatic skin in relation to pruritus.
    Chang SE; Han SS; Jung HJ; Choi JH
    Br J Dermatol; 2007 Jun; 156(6):1272-7. PubMed ID: 17535226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors.
    Nakamura M; Toyoda M; Morohashi M
    Br J Dermatol; 2003 Oct; 149(4):718-30. PubMed ID: 14616362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations.
    Czarnecka-Operacz M; Polańska A; Klimańska M; Teresiak-Mikołajczak E; Molińska-Glura M; Adamski Z; Jenerowicz D
    Postepy Dermatol Alergol; 2015 Dec; 32(6):426-30. PubMed ID: 26755905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and Cellular Mechanisms of Itch in Psoriasis.
    Komiya E; Tominaga M; Kamata Y; Suga Y; Takamori K
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus.
    Teresiak-Mikołajczak E; Czarnecka-Operacz M; Jenerowicz D; Silny W
    Postepy Dermatol Alergol; 2013 Oct; 30(5):286-92. PubMed ID: 24353488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch in psoriasis: epidemiology, clinical aspects and treatment options.
    Prignano F; Ricceri F; Pescitelli L; Lotti T
    Clin Cosmet Investig Dermatol; 2009 Feb; 2():9-13. PubMed ID: 21436964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itching for answers: Prevalence and severity of pruritus in psoriasis.
    Dickison P; Swain G; Peek JJ; Smith SD
    Australas J Dermatol; 2018 Aug; 59(3):206-209. PubMed ID: 29280133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.
    Yosipovitch G; Goon A; Wee J; Chan YH; Goh CL
    Br J Dermatol; 2000 Nov; 143(5):969-73. PubMed ID: 11069504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of pruritus in psoriasis.
    Reich A; Szepietowski JC
    Mediators Inflamm; 2007; 2007():64727. PubMed ID: 18288273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pruritus in psoriasis : Profile and therapy].
    Tsianakas A; Mrowietz U
    Hautarzt; 2016 Aug; 67(8):601-5. PubMed ID: 27376751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to intradermal injections of substance P in psoriasis patients with pruritus.
    Amatya B; Nordlind K; Wahlgren CF
    Skin Pharmacol Physiol; 2010; 23(3):133-8. PubMed ID: 20051714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of pruritus in various clinical variants of psoriasis: Final report of the binational, multicentre, cross-sectional study.
    Jaworecka K; Kwiatkowska D; Marek-Józefowicz L; Tamer F; Stefaniak A; Szczegielniak M; Chojnacka-Purpurowicz J; Gulekon A; Szepietowski JC; Narbutt J; Owczarczyk-Saczonek A; Reich A
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):787-795. PubMed ID: 36606568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRURITUS CHARACTERISTICS IN A LARGE ITALIAN COHORT OF PSORIATIC PATIENTS.
    Damiani G; Cazzaniga S; Conic RR; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1316-1324. PubMed ID: 31736536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis.
    Bodoor K; Al-Qarqaz F; Heis LA; Alfaqih MA; Oweis AO; Almomani R; Obeidat MA
    Clin Cosmet Investig Dermatol; 2020; 13():419-424. PubMed ID: 32606880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pruritus in psoriasis: An update.
    Szepietowski JC; Reich A
    Eur J Pain; 2016 Jan; 20(1):41-6. PubMed ID: 26415584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Aspects of Pruritus Pathogenesis in Psoriasis.
    Jaworecka K; Muda-Urban J; Rzepko M; Reich A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neuroimmune circuits and pruritus in psoriasis.
    Ayasse MT; Buddenkotte J; Alam M; Steinhoff M
    Exp Dermatol; 2020 Apr; 29(4):414-426. PubMed ID: 31954075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.